Eloxx Pharmaceuticals, Inc. Intellectual Property Contracts & Agreements
17 Contracts & Agreements
- License Agreements (17 contracts)
- Amendment to Research and License Agreement, by and among Eloxx Pharmaceuticals, Inc., Eloxx Pharmaceuticals Ltd. and Technion Research & Development Foundation Ltd., dated as of... (Filed With SEC on June 14, 2018)
- Ninth Addendum to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated July 16, 2017 (Filed With SEC on March 16, 2018)
- Eighth Addendum to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated July 16, 2017 (Filed With SEC on March 16, 2018)
- Seventh Addendum to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated March 6, 2016 (Filed With SEC on March 16, 2018)
- Sixth Addendum to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated January 11, 2016 (Filed With SEC on March 16, 2018)
- Fifth Addendum to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated June 2, 2015 (Filed With SEC on March 16, 2018)
- Fourth Addendum to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated April 29, 2015 (Filed With SEC on March 16, 2018)
- Third Addendum to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated February 9, 2015 (Filed With SEC on March 16, 2018)
- Second Addendum to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated January 21, 2015 (Filed With SEC on March 16, 2018)
- First Addendum to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated August 3, 2014 (Filed With SEC on March 16, 2018)
- Third Amendment to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated June 9, 2014 (Filed With SEC on March 16, 2018)
- Second Amendment to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated January 14, 2014 (Filed With SEC on March 16, 2018)
- First Amendment to Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated November 26, 2013 (Filed With SEC on March 16, 2018)
- Research and License Agreement by and between Technion Research and Development Foundation Ltd. and Eloxx Pharmaceuticals Ltd., dated August 29, 2013 (Filed With SEC on March 16, 2018)
- BIOFUELS EVALUATION AND LICENSE AGREEMENT (Filed With SEC on May 14, 2012)
- LICENSE AGREEMENT between BAYER CROPSCIENCE GmbH and SENESCO TECHNOLOGIES, INC. (Filed With SEC on February 14, 2007)
- COMMERCIAL LICENSE AGREEMENT (Filed With SEC on February 14, 2007)
